AbbVie Stock Chart Shows Pocket Pivot Cluster On FDA Breakthrough Therapy

Abbvie stock is a good long-term buy and hold on a “dream-team” pipeline of phase 3 trials.

Abbvie stock


  • AbbVie just received breakthrough therapy designation from the FDA for JAK1 inhibitor.
  • The company has a robust pipeline of drugs in phase 3 trials.
  • Over the last 5 years, revenue has been growing by 8.21% per year.
  • AbbVie stock has a bullish pocket pivot cluster with positive Twiggs Money Flow.
  • Author: Lance Jepsen

    For ethical purposes, I try not to hold any position in any stock I profile on unless specifically stated in the article. Owner of Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade.

    Sofi AI Market Sentiment Gauge

    Sofi AI Market Sentiment Gauge

    Market is neither overbought or oversold.